Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)

被引:6
|
作者
AlMohanna, Zainab [1 ]
Snavely, Anna C. [2 ]
Viviano, James P. [1 ]
Bischoff, Werner E. [1 ]
机构
[1] Atrium Hlth Wake Forest Baptist, Infect Prevent & Hlth Syst Epidemiol, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Biostat & Data Sci, Winston Salem, NC 27101 USA
关键词
Healthcare associated infections; Contact precautions; Personal protective equipment; Central Line Associated Bloodstream  Infections; MRSA bacteremia LabID events; INTENSIVE-CARE-UNIT; TRANSMISSION; VRE; ENTEROCOCCUS; ORGANISMS; BACTERIA; GLOVE;
D O I
10.1016/j.ajic.2021.10.044
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections (HAI). Contact isolation has been traditionally implemented to stop transmission but its impact is increasingly questioned. Methods: A single center, retrospective, nonrandomized, observational, quasi-experimental study compared MRSA HAI rates between pre-/postdiscontinuation of MRSA contact isolation in a tertiary university hospital over 68 months. Data on primary outcomes, Central line-associated bloodstream infections and MRSA LabID bacteremia events, were analyzed by interrupted time series design using segmented Poisson regression modeling. As secondary outcomes catheter-associated urinary tract infections , ventilator-associated pneu-monia , surgical site infections and hospital-associated pneumonia were compared using Fisher's exact tests. Current savings due to discontinuation were calculated based on gown use. Results: Two hundred and ninty-five patients developed 399 HAIs. Infection rates between pre-and postin-terventions were as follows: Central line-associated bloodstream infections: (0.02% vs 0.02%; P-value = .64), MRSA LabID events: (0.01% vs 0.02%; P-value = .32), hospital-associated pneumonia: (0.01% vs 0.01%; P- value = .64), catheter-associated urinary tract infections: (0% vs 0.01%; P-value = .56), ventilator-associated pneumonia: (0.01% vs 0.01%; P-value = .32), surgical site infections (0.55% vs 0.15%; P-value = .03). Savings amount to $139,228 annually. Conclusions: Discontinuing CP did not negatively impact endemic MRSA HAI rates between pre-postdiscon-tinuation periods and saved costs for isolation materials. (c) 2021 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页码:336 / 341
页数:6
相关论文
共 50 条
  • [31] Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species
    Cuny, Christiane
    Friedrich, Alexander
    Kozytska, Svetlana
    Layer, Franziska
    Nuebel, Ulrich
    Ohlsen, Knut
    Strommenger, Birgit
    Walther, Birgit
    Wieler, Lothar
    Witte, Wolfgang
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2010, 300 (2-3) : 109 - 117
  • [32] The Effects of Securinega Virosa Leaves on Methicillin-Resistant Staphylococcus Aureus (MRSA)
    Oghenemaro, Enwa Felix
    Oise, Ikpefen Emmanuel
    Cynthia, Damera
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2021, 10 (02): : 29 - 34
  • [33] Molecular detection of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) isolates in raw chicken meat
    Aklilu, E.
    Nurhardy, A. D.
    Mokhtar, A.
    Zahirul, I. K.
    Rokiah, Siti A.
    INTERNATIONAL FOOD RESEARCH JOURNAL, 2016, 23 (01): : 322 - 325
  • [34] Novel inhibitors of the methicillin-resistant Staphylococcus aureus (MRSA)-pyruvate kinase
    El-Sayed, Mardia Telep
    Zoraghi, Roya
    Reiner, Neil
    Suzen, Sibel
    Ohlsen, Knut
    Lalk, Michael
    Altanlar, Nurten
    Hilgeroth, Andreas
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 1666 - 1671
  • [35] Bioactive amide and -aminophosphonate inhibitors for methicillin-resistant Staphylococcus aureus (MRSA)
    Boshta, Nader M.
    Elgamal, Enas A.
    El-Sayed, Ibrahim E. T.
    MONATSHEFTE FUR CHEMIE, 2018, 149 (12): : 2349 - 2358
  • [36] Recent Developments in Methicillin-Resistant Staphylococcus aureus (MRSA) Treatment: A Review
    Nandhini, Palanichamy
    Kumar, Pradeep
    Mickymaray, Suresh
    Alothaim, Abdulaziz S.
    Somasundaram, Jayaprakash
    Rajan, Mariappan
    ANTIBIOTICS-BASEL, 2022, 11 (05):
  • [37] Antibiotic resistant Staphylococcus aureus in hospital wastewaters and sewage treatment plants with special reference to methicillin-resistant Staphylococcus aureus (MRSA)
    Thompson, J. M.
    Guendogdu, A.
    Stratton, H. M.
    Katouli, M.
    JOURNAL OF APPLIED MICROBIOLOGY, 2013, 114 (01) : 44 - 54
  • [38] Interaction Between Methicillin-Resistant Staphylococcus aureus (MRSA) and Acanthamoeba polyphaga
    de Souza, Thamires Klein
    Soares, Scheila Silva
    Benitez, Lisianne Brittes
    Rott, Marilise Brittes
    CURRENT MICROBIOLOGY, 2017, 74 (05) : 541 - 549
  • [39] Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan
    Liu, Chia-Ying
    Lai, Chih-Cheng
    Chiang, Hsiu-Tzy
    Lu, Min-Chi
    Wang, Ling-Fang
    Tsai, Tsai-Ling
    Kang, Mei-Yu
    Jan, Yi-Ni
    Lo, Yi-Ting
    Ko, Wen-Chien
    Tseng, Shu-Hui
    Lee, Chun-Ming
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 52 (01) : 62 - 74
  • [40] Within-host genomic evolution of methicillin-resistant Staphylococcus aureus in long-term carriers
    Larsen, Tine Graakjaer
    Castruita, Jose Alfredo Samaniego
    Worning, Peder
    Westh, Henrik
    Bartels, Mette Damkjaer
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 108 (01) : 16 - 16